Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Howard, Natasha ^a   Durrani, Naeem ^b   Sanda, Sanda ^a   Beshir, Khalid ^a   Hallett, Rachel ^a   Rowland, Mark ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Department of Research and Development   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; PROTOZOAL DNA;

ADOLESCENT; ARTICLE; BLOOD SMEAR; CHILD; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GAMETOCYTE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NEWBORN; PAKISTAN; PARASITE CLEARANCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REFUGEE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; ADULT; AFGHANISTAN; AGED; ANIMAL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; AFGHANISTAN; AGED; AGED, 80 AND OVER; ANIMALS; ANTIMALARIALS; BLOOD; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PAKISTAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REFUGEES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959439487     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-171     Document Type: Article

References (37)

1. Disease and dislocation: the impact of refugee movements on the geography of malaria in NWFP, Pakistan. JH Kazmi K Pandit, Soc Sci Med 2001 52 1043 1055 10.1016/S0277-9536(00)00211-2 11266048 (Pubitemid 32065785)
2. Afghan refugees and the temporal and spatial distribution of malaria in Pakistan. M Rowland MA Rab T Freeman N Durrani N Rehman, Soc Sci Med 2002 55 2061 2072 10.1016/S0277-9536(01)00341-0 12406471 (Pubitemid 36158904)
3. Departmental audit of malaria control programme 2001-2005 north west frontier province (NWFP). SA Asif, J Ayub Med Coll Abbottabad 2008 20 98 102 19024199
4. Resistance of falciparum malaria to chloroquine and sulfadoxine- pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. M Rowland N Durrani S Hewitt E Sondorp, Trop Med Int Health 1997 2 1049 1056 10.1046/j.1365-3156.1997. d01-185.x 9391507 (Pubitemid 27505238)
5. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. I Shah M Rowland P Mehmood C Mujahid F Razique S Hewitt N Durrani, Ann Trop Med Parasitol 1997 91 591 602 10.1080/00034989760680 9425361 (Pubitemid 27434593)
6. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. MA Rab TW Freeman N Durrani D de Poerck MW Rowland, Ann Trop Med Parasitol 2001 95 41 46 10.1080/00034980020035906 11235552 (Pubitemid 32178731)
7. Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children. JD Sexton P Deloron L Bugilimfura A Ntilivamunda M Neill, Am J Trop Med Hyg 1988 38 237 243 3281488 (Pubitemid 18086101)
8. Transmission and control of vivax malaria in Afghan refugee settlements in Pakistan. M Rowland S Hewitt N Durrani N Bano R Wirtz, Trans R Soc Trop Med Hyg 1997 91 252 255 10.1016/S0035-9203(97)90065-1 9231188 (Pubitemid 27261157)
9. Amodiaquine resistance in Plasmodium falciparum malaria is associated with the pfcrt 72-76 SVMNT allele in Afghanistan. K Beshir CJ Sutherland I Merinopoulos N Durrani T Leslie M Rowland RL Hallett, Antimicrob Agents Chemother 2010
10. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, Geneva: World Health Organization 2003 vol. Document No. WHO/HTM/RBM/2003.50
11. Clinical trials registry and database. http://clinicaltrials.gov
12. Practical chemotherapy of malaria. WHO, WHO Technical Report Series No 805 Geneva 1990
13. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. CV Plowe A Djimde M Bouare O Doumbo TE Wellems, Am J Trop Med Hyg 1995 52 565 568 7611566
14. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. GS Humphreys I Merinopoulos J Ahmed CJ Whitty TK Mutabingwa CJ Sutherland RL Hallett, Antimicrob Agents Chemother 2007 51 991 997 10.1128/AAC.00875-06 17194834 (Pubitemid 46355285)
15. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. L Khatoon FN Baliraine M Bonizzoni SA Malik G Yan, Am J Trop Med Hyg 2009 81 525 528 19706926
16. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. S Picot P Olliaro F de Monbrison AL Bienvenu RN Price P Ringwald, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
17. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. IF Khalil M Alifrangis DS Tarimo T Staalso GM Satti TG Theander AM Ronn IC Bygbjerg, Ann Trop Med Parasitol 2005 99 441 448 10.1179/136485905X46441 16004703 (Pubitemid 40992388)
18. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. J Keen GA Farcas K Zhong S Yohanna MW Dunne KC Kain, J Clin Microbiol 2007 45 2889 2893 10.1128/JCM.02291-06 17609321 (Pubitemid 47417331)
19. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. M Tekete AA Djimde AH Beavogui H Maiga I Sagara B Fofana D Ouologuem S Dama A Kone D Dembele,, et al. Malar J 2009 8 34 10.1186/1475-2875-8-34 19245687
20. Bruce-Chwatt's Essential Malariology - International Student Edition. H Gilles DA Warrell Eds, London: Arnold 3 1993
21. Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. T Leslie H Kaur N Mohammed K Kolaczinski RL Ord M Rowland, Emerg Infect Dis 2009 15 1753 1759 19891862
22. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan. N Durrani T Leslie S Rahim K Graham F Ahmad M Rowland, Trop Med Int Health 2005 10 521 529 10.1111/j.1365-3156.2005.01429.x 15941414 (Pubitemid 40806657)
23. Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2. NK Ghanchi A Martensson J Ursing S Jafri S Bereczky R Hussain MA Beg, Malar J 2010 9 1 10.1186/1475-2875-9-1 20043863
24. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. J Ursing PE Kofoed A Rodrigues L Rombo JP Gil, Am J Trop Med Hyg 2007 76 844 848 17488902 (Pubitemid 351627666)
25. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. JM Sa O Twu K Hayton S Reyes MP Fay P Ringwald TE Wellems, Proc Natl Acad Sci USA 2009 106 18883 18889 10.1073/pnas.0911317106 19884511
26. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. M Alifrangis MB Dalgaard JP Lusingu LS Vestergaard T Staalsoe AT Jensen A Enevold AM Ronn IF Khalil DC Warhurst,, et al. J Infect Dis 2006 193 1738 1741 10.1086/504269 16703518 (Pubitemid 43839479)
27. Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau. J Ursing PE Kofoed A Rodrigues Y Bergqvist L Rombo, Antimicrob Agents Chemother 2009 53 180 185 10.1128/AAC.01111-08 18955514
28. Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage? J Ursing BA Schmidt M Lebbad PE Kofoed F Dias JP Gil L Rombo, Infect Genet Evol 2007 7 555 561 10.1016/j.meegid.2007.03.006 17467343 (Pubitemid 47342374)
29. Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations. PE Kofoed J Ursing A Poulsen A Rodrigues Y Bergquist P Aaby L Rombo, Trans R Soc Trop Med Hyg 2007 101 231 238 10.1016/j.trstmh.2006. 05.008 16904718 (Pubitemid 46043055)
30. Return of chloroquine antimalarial efficacy in Malawi. MK Laufer PC Thesing ND Eddington R Masonga FK Dzinjalamala SL Takala TE Taylor CV Plowe, N Engl J Med 2006 355 1959 1966 10.1056/NEJMoa062032 17093247 (Pubitemid 44708015)
31. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. R Ord N Alexander S Dunyo R Hallett M Jawara G Targett CJ Drakeley CJ Sutherland, J Infect Dis 2007 196 1613 1619 10.1086/522154 18008244 (Pubitemid 351411958)
32. Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. AM Abdel-Muhsin MJ Mackinnon E Ali KA Nassir el S Suleiman S Ahmed D Walliker HA Babiker, J Infect Dis 2004 189 1239 1244 10.1086/382509 15031793 (Pubitemid 38457249)
33. Compliance with 14-day primaquine therapy for radical cure of vivax malaria - a randomized placebo-controlled trial comparing unsupervised with supervised treatment. T Leslie MA Rab H Ahmadzai N Durrani M Fayaz J Kolaczinski M Rowland, Trans R Soc Trop Med Hyg 2004 98 168 173 10.1016/S0035-9203(03) 00041-5 15024927 (Pubitemid 38949897)
34. Malaria control in Afghanistan: progress and challenges. J Kolaczinski K Graham A Fahim S Brooker M Rowland, Lancet 2005 365 1506 1512 10.1016/S0140-6736(05)66423-9 15850637 (Pubitemid 40591697)
35. A health facility based case-control study of effectiveness of insecticide treated nets: potential for selection bias due to pre-treatment with chloroquine. J Webster D Chandramohan T Freeman B Greenwood AU Kamawal F Rahim M Rowland, Trop Med Int Health 2003 8 196 201 10.1046/j.1365-3156.2003.01013.x 12631307 (Pubitemid 36398802)
36. Sulfadoxine-pyrimethamine remains efficacious against uncomplicated, Plasmodium falciparum malaria in north-eastern Afghanistan. N Ezard P Nellepalli AW Asha, Ann Trop Med Parasitol 2004 98 85 88 10.1179/000349804225003019 15000735 (Pubitemid 38210469)
37. Monitoring and deterring drug-resistant malaria in the era of combination therapy. MK Laufer AA Djimde CV Plowe, Am J Trop Med Hyg 2007 77 160 169 18165489